Dyslipidemia, one of the hallmarks of metabolic syndrome, is characterized by altered levels of triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), as well as other markers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT). This evidence concerns the gene GPT and metabolic syndrome.